A Montgomery County biopharmaceutical company taking on the opioid addiction epidemic has raised $3.9 million in an equity financing.
The private stock sale by Mirata Pharmaceuticals of Plymouth Meeting, Pa., was disclosed in a filing the company made earlier this month with the Securities and Exchange Commission, writes John George at bizjournals.com.
The company was founded in 2017 by a group that included Maurits Geerlings, the president and CEO of Formula Pharmaceuticals in Berwyn, Pa.
On its Facebook page, Mirata states it is “developing new options for patients and physicians that provide the powerful pain relieving benefits of opioids, but without the significant side effects.”
To read the full article, click here.